Less than six months after earning FDA clearance for its PrecisionTAVI product, DASI Simulations Founder and Chief Technology Officer Dr. Lakshmi (Prasad) Dasi announced today that the Centers for Medicare & Medicaid…
Nanowear, a leader in healthcare-at-home remote diagnostics, announced that its nanotechnology-enabled wearable and software platform, SimpleSenseTM, has received FDA 510(k) clearance for a novel AI-enabled Software-as-a-Medical Device (SaMD). As the…
Neuspera Medical, Inc., a neuromodulation company pioneering the Neuspera Implantable Sacral Neuromodulation (SNM) System, today announced it has completed patient enrollment and implant procedures for the pivotal clinical trial (SANS-UUI)…
PhotoPharmics, an innovator in Parkinson’s disease research and treatment, today announced the successful first close of a $16 million investment round. The investment round, led by Kickstart Fund, a venture…
RIVANNA®, developers of world-first, imaging-based medical solutions, announced they received a $2.9 million grant from the National Institutes of Health (NIH). The grant will further the development of Accuro® 3S,…
Fire chiefs from Canada, Mexico, the United Kingdom, and the U.S. participated in the National Fire Protection Association® (NFPA®) Urban Fire Forum (UFF) last week at NFPA headquarters in Quincy, MA, endorsing five important…
ReGelTec, Inc., announced that the U.S. Food and Drug Administration has approved an IDE for the company’s pivotal study to support premarket approval of its HYDRAFIL® System. The HYDRAFIL System…
Regenesis Biomedical, Inc., a medical device company focused on safe, non-drug, pain management, announced today commercialization of the new Reprieve by Regenesis™ device (Reprieve). Reprieve is the only home-use shortwave…
Francis Medical, Inc., a privately held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of prostate, kidney, and bladder cancer, today announced the…
Obvius Robotics, Inc., a medical device company that has developed an innovative technology platform for performing percutaneous access, today announced the successful completion of its first human cases.